Connection

Gary Gilkeson to Immunosuppressive Agents

Back to Details
This is a "connection" page, showing publications Gary Gilkeson has written about Immunosuppressive Agents.
Gary Gilkeson
Connection Strength
0.452
Immunosuppressive Agents
  1. New therapies and preventive strategies to treat and minimize damage in lupus. Curr Rheumatol Rep. 2005 Dec; 7(6):457-62.
    View in: PubMed
    Score: 0.198
  2. Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy. Clin Rheumatol. 2014 Nov; 33(11):1611-9.
    View in: PubMed
    Score: 0.091
  3. N,N,-diethyl-m-toluamide (DEET) suppresses humoral immunological function in B6C3F1 mice. Toxicol Sci. 2009 Mar; 108(1):110-23.
    View in: PubMed
    Score: 0.062
  4. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med. 2005 Nov 24; 353(21):2219-28.
    View in: PubMed
    Score: 0.049
  5. Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid. J Immunol. 2004 Sep 15; 173(6):4171-8.
    View in: PubMed
    Score: 0.046
  6. Systemic lupus erythematosus. Diagnosis and treatment. Med Clin North Am. 1997 Jan; 81(1):113-28.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.